Radiology Business

OCTOBER 31, 2024

Leaders said the funding will help Blue Earth to further advance its development of PSMA-targeted therapies for prostate cancer.

Radiopharmaceuticals 272

Radiopharmaceuticals Imaging IT 272

Radiology Business

SEPTEMBER 10, 2024

NRC estimates that 29 of these “medical events” occurred between 2021 and 2023, with “many” involving new therapeutic radiopharma procedures.

Radiopharmaceuticals 280

Radiopharmaceuticals Medical 280

Radiology Business

MAY 3, 2024

The Swiss drugmaker said the deal will bolster its research infrastructure and clinical supply capabilities, with an eye toward improving oncologic care.

Radiopharmaceuticals 280

Radiopharmaceuticals Clinic IT 280

AuntMinnie

MAY 8, 2024

Theranostics treatments are used with increasing frequency now since the approvals and expansions of Lutathera (lutetium-177 [Lu-177]) DOTATATE, a radiopharmaceutical for neuroendrocrine tumors (NETs) and Pluvicto, Lu-177 PSMA-617, for prostate cancer.

Radiopharmaceuticals 189

Radiopharmaceuticals Nuclear Medicine Radiation Hospital 189

Radiology Business

MAY 21, 2024

The Indianapolis-based drugmaker can hit the hefty total by reaching certain clinical, regulatory and commercial milestones.

Radiopharmaceuticals 273

Radiopharmaceuticals Clinic 273

Radiology Business

OCTOBER 7, 2024

Founded in 2019, the firm is focused on developing products for the diagnosis and therapy of blood cancers and other indications not addressed by nuclear medicine.

Radiopharmaceuticals 263

Radiopharmaceuticals Nuclear Medicine 263

Radiology Business

OCTOBER 1, 2024

The Boston clinical stage biotechnology company is working to develop new products to treat a range of solid tumors.

Radiopharmaceuticals 262

Radiopharmaceuticals Clinic 262

Radiology Business

JUNE 28, 2024

One of the largest radiopharma companies in the world is acquiring global rights to a pair of novel therapeutic and diagnostic drugs used to target a peptide receptor overexpressed in prostate and breast cancers.

Radiopharmaceuticals 263

Radiopharmaceuticals Diagnostic 263

Radiology Business

JULY 12, 2024

For years, the agency has packaged payment for nuclear imaging agents with the procedure, but this has created a barrier for those who require pricier new drugs.

Radiopharmaceuticals 253

Radiopharmaceuticals Diagnostic Imaging 253

Radiology Business

NOVEMBER 20, 2024

The Australian company will secure exclusive worldwide rights to a suite of diagnostic and therapeutic candidates geared toward urological cancers.

Radiopharmaceuticals 263

Radiopharmaceuticals Diagnostic Imaging 263

AuntMinnie

JUNE 8, 2023

Radiopharmaceutical manufacturer SpectronRx and nuclear medicine drug distributo.

Radiopharmaceuticals 130

Radiopharmaceuticals Nuclear Medicine Clinic 130

Health Imaging

MARCH 7, 2025

Trial results thus far indicate the drug can significantly extend progression-free survival compared to current standard of care treatments.

Radiopharmaceuticals 198

Radiopharmaceuticals 198

Radiology Business

SEPTEMBER 23, 2024

RLS operates America’s only Joint Commission-accredited radiopharmacy network, with 31 locations covering over 85% of the U.S. population.

Radiopharmaceuticals 258

Radiopharmaceuticals Imaging 258

Radiology Business

SEPTEMBER 11, 2023

The company has developed a portfolio of nuclear medicine solutions including "lead candidate" MC-339, used for treating small cell lung cancer.

Nuclear Medicine 264

Nuclear Medicine Radiopharmaceuticals 264

Open Medscience

SEPTEMBER 25, 2024

Regulatory radiopharmaceutical production requires strict adherence to safety standards, ensuring quality and patient safety. The post Regulatory Considerations in Radiopharmaceutical Production appeared first on Open MedScience.

Radiopharmaceuticals 105

Radiopharmaceuticals Patient Safety Medical 105

AuntMinnie

JUNE 22, 2023

Read more on AuntMinnie.com Related Reading: RLS appoints new director of regulatory affairs SpectronRx, RLS ink radiopharmaceutical supply deal RLS lands radiopharmaceutical supplier deal from Premier Sofie to launch FAPI-PET phase II trial First patient imaged in Sofie's FAPI-PET trial

Radiopharmaceuticals 130

Radiopharmaceuticals Imaging 130

Radiology Business

OCTOBER 18, 2023

Nucleus RadioPharma will use the money to establish manufacturing facilities—with one located in Rochester, Minnesota, near Mayo—and build new technology for distribution.

Radiopharmaceuticals 279

Radiopharmaceuticals Clinic Healthcare Healthcare 279

AuntMinnie

JUNE 24, 2024

Jubilant Radiopharma plans to invest $50 million to expand its PET radiopharmaceutical manufacturing capacity. The money will be used to add six manufacturing facilities across the U.S. to the company's network, bringing its total to nine. Jubilant expects the new sites to be up and running in about two years, it said.

Radiopharmaceuticals 130

Radiopharmaceuticals IT 130

Radiology Business

JULY 14, 2023

The agency issued its solicitation as part of the 2024 Hospital Outpatient Prospective Payment System proposed rule, released late Thursday.

Radiopharmaceuticals 246

Radiopharmaceuticals Diagnostic Hospital IT 246

AuntMinnie

MARCH 26, 2025

Ultimately, most hospitals conducting trials receive doses of these eight radionuclides from upstream radiopharmaceutical production facilities, with U.S. This next generation of radionuclides is showing promise in a broad range of cancers, she said.

Nuclear Medicine 179

Nuclear Medicine Radiopharmaceuticals Patient Care Hospital 179

Radiology Business

JULY 23, 2024

The Melbourne, Australia-based radiopharmaceutical firm plans to use the proceeds to accelerate development of products in its theranostics portfolio

Pharmaceutical 297

Pharmaceutical Radiopharmaceuticals Imaging IT 297

AuntMinnie

SEPTEMBER 13, 2023

Senate MITA hails radiopharmaceutical legislation Read more on AuntMinnie.com Related Reading: ACR urges full coverage for amyloid PET scans CMS proposal covers PET scans for Alzheimer’s disease MITA praises FDA for Leqembi approval FIND Act reintroduced in U.S.

Radiopharmaceuticals 130

Radiopharmaceuticals PET Scan Medical Imaging Disease 130

AuntMinnie

JULY 10, 2024

Centers for Medicare and Medicaid Services (CMS) proposed a new reimbursement plan July 10 for diagnostic PET scans that would provide separate payments for radiopharmaceuticals, as well as an extra payment for hospitals when they use domestically produced technetium-99m (Tc-99m).

Nuclear Medicine 305

Nuclear Medicine Radiopharmaceuticals Imaging Medicare 305

Health Imaging

APRIL 5, 2024

The supply agreement with Eckert & Ziegler will ensure radiopharmaceuticals are available for PET imaging and cancer treatment plans.

Radiopharmaceuticals 277

Radiopharmaceuticals IT Imaging 277

Radiology Business

NOVEMBER 5, 2024

CMS is moving forward with a proposal to issue separate reimbursement for radiopharmaceuticals—a change long lobbied for by the imaging industry.

Diagnostic Imaging 279

Diagnostic Imaging Medicare Radiopharmaceuticals Diagnostic 279

AuntMinnie

MARCH 25, 2025

Actinium will continue developing its lead radiopharmaceutical product Actimab-A, as well as additional early and late-stage development candidates for both U.S. Eckert & Ziegler has entered into an agreement with Actinium Pharmaceuticals to supply the firm with the radioisotope actinium-225 (Ac-225). and international clinical trials.

Pharmaceutical 130

Pharmaceutical Radiopharmaceuticals Clinic IT 130

AuntMinnie

JANUARY 16, 2025

Oliverio joins Actineer with over 30 years of leadership experience across the nuclear medicine, medical device, and radiopharmaceutical industries, including roles at Ionetix, Imagin Molecular, and Positron.

Nuclear Medicine 130

Nuclear Medicine Medical Device Radiopharmaceuticals Medical 130

AuntMinnie

JULY 8, 2024

Nuclear medicine firm Curium has submitted a new drug application (NDA) for its lutetium-177 (Lu-177) DOTATATE radiopharmaceutical for treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETS).

Nuclear Medicine 243

Nuclear Medicine Radiopharmaceuticals Radiation IT 243

AuntMinnie

FEBRUARY 1, 2024

ITM Isotope Technologies Munich SE (ITM), a radiopharmaceutical biotech company, recently received a wholesale license issued by the New Jersey Department of Health to operate as a virtual manufacturer. Since then, it has been preparing for potential market registration of its targeted radiopharmaceutical pipeline product candidates.

Radiopharmaceuticals 242

Radiopharmaceuticals IT 242

AuntMinnie

OCTOBER 14, 2024

These SSTRs can be targeted both with gallium-68 (Ga-68) imaging agents and therapeutic lutetium-177 (Lu-177) radiopharmaceuticals using a so-called theranostics approach. Meningiomas are the most common primary adult intracranial tumors and most meningiomas show high expression of somatostatin receptors (SSTRs). In the U.S.,

Nuclear Medicine 276

Nuclear Medicine Radiopharmaceuticals Insurance Clinic 276

AuntMinnie

FEBRUARY 26, 2025

SPECT and low-dose CT scans could be added for areas with suspected radiopharmaceutical uptake. Data on radiation doses and the administration of contrast agents or radiopharmaceuticals were also collected. For bone scans, radiopharmaceutical injections averaged 693.87 67.32 DL2 had the shortest mean scan time (0.27 0.04

Bone Scan 130

Bone Scan Radiopharmaceuticals Imaging Modalities Bone Scintigraphy 130

Imaging Technology

NOVEMBER 7, 2024

Under the new policy, CMS will unpackage and pay separately for diagnostic radiopharmaceuticals with per-day costs exceeding $630, removing financial barriers that have long hindered patient access to essential nuclear medicine diagnostic procedures. tim.hodson Thu, 11/07/2024 - 11:25 Nov.

Nuclear Medicine 97

Nuclear Medicine Radiopharmaceuticals Medicare Diagnostic 97

AuntMinnie

NOVEMBER 20, 2024

The company has entered into asset purchase and exclusive worldwide in-license agreements for a suite of clinically validated FAP-targeting therapeutic and precision medicine radiopharmaceutical candidates. Telix’s development program will initially focus on the treatment of bladder cancer.

Nuclear Medicine 130

Nuclear Medicine Pharmaceutical Radiopharmaceuticals Clinic 130

AuntMinnie

SEPTEMBER 30, 2024

A radiopharmaceutical therapy that lengthens progression-free survival for patients with neuroendocrine cancer could help treat meningioma sufferers, according to research presented at the American Society for Radiation Oncology (ASTRO) meeting. Nearly 80% of patients in our study were progression-free after six months," he said.

Radiation Oncology 299

Radiation Oncology Radiopharmaceuticals Radiation Clinic 299

AuntMinnie

JULY 12, 2024

Reshaping the hospital's nuclear medicine and radiopharmaceutical strategy toward theranostics involves intensive and inclusive planning, Beyder explained at SNMMI. Underwood led the nuclear medicine and radiopharmaceutical therapy team within radiation safety at Mayo Clinic and directly supports the program in Rochester.

Nuclear Medicine 264

Nuclear Medicine Radiation Oncology Radiopharmaceuticals Radiation 264

AuntMinnie

MAY 1, 2024

Food and Drug Administration (FDA) has approved Novartis' Lutathera (lutetium-177 [Lu-177]) DOTATATE radiopharmaceutical for treatment of pediatric patients who are 12 years old and older with somatostatin receptor (SSTR)-positive gastroentropancreatic neuroendocrine tumors (GEP-NETs).

Radiopharmaceuticals 240

Radiopharmaceuticals Pharmaceutical Radiology 240

AuntMinnie

MARCH 27, 2025

Pass-through payment status will allow the CMS to provide separate payments for the radiopharmaceutical and the PET-CT scan when performed with Flyrcado in the hospital outpatient setting. Flyrcado will be unveiled at the ACC conference on March 29.

Healthcare 130

Healthcare Healthcare Medicare Radiopharmaceuticals 130